Slit: A Protein Implicated in Cancer and Other Diseases (P10918)

Target Name: Slit

NCBI ID: P10918

Slit

Other Name(s): None

Slit: A Protein Implicated in Cancer and Other Diseases

Slit (nonspecified subtype) is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell division and has been implicated in a number of diseases, including cancer. In recent years, researchers have been interested in using Slit as a drug target or biomarker because of its unique biology and the potential impact it could have on human health.

Slit is a transmembrane protein that is involved in a number of different signaling pathways. It is a critical regulator of the cell cycle, helping to control the growth and division of cells. Slit is also involved in the development and maintenance of tissues, including blood vessels and the nervous system.

One of the key features of Slit is its ability to interact with a variety of different proteins, including those that are involved in cell division and growth. This makes it an attractive target for drugs that are designed to disrupt these signaling pathways and prevent the growth and spread of cancer.

In addition to its role in cell division, Slit is also involved in the regulation of cell adhesion. This is the process by which cells stick together and form tissues, and is critical for the development and maintenance of tissues and organs.

Slit has also been shown to be involved in the regulation of angiogenesis, the process by which new blood vessels are formed in the body. This is important for the development of new treatments for a variety of conditions, including cancer.

In addition to its role in cell biology, Slit is also a potential biomarker for a variety of diseases. This is because its expression is often affected by the development and progression of diseases, making it a useful indicator of the overall health of a patient.

Overall, Slit is a fascinating protein that has the potential to be a drug target or biomarker. Its unique biology and the range of diseases it is involved in make it an attractive target for research and development. Further studies are needed to fully understand the potential of Slit and its potential impact on human health.

Protein Name: Slit (nonspecified Subtype)

The "Slit Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Slit comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets